KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Tax Provisions (2016 - 2025)

Nektar Therapeutics (NKTR) has 16 years of Tax Provisions data on record, last reported at -$33000.0 in Q3 2025.

  • For Q3 2025, Tax Provisions fell 466.67% year-over-year to -$33000.0; the TTM value through Sep 2025 reached -$418000.0, down 419.08%, while the annual FY2024 figure was -$229000.0, 281.67% down from the prior year.
  • Tax Provisions reached -$33000.0 in Q3 2025 per NKTR's latest filing, up from -$188000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $3.1 million in Q4 2022 and bottomed at -$249000.0 in Q4 2024.
  • Average Tax Provisions over 5 years is $174421.1, with a median of $9000.0 recorded in 2024.
  • Peak YoY movement for Tax Provisions: soared 78700.0% in 2022, then plummeted 508.7% in 2025.
  • A 5-year view of Tax Provisions shows it stood at -$4000.0 in 2021, then skyrocketed by 78700.0% to $3.1 million in 2022, then plummeted by 96.47% to $111000.0 in 2023, then tumbled by 324.32% to -$249000.0 in 2024, then skyrocketed by 86.75% to -$33000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were -$33000.0 in Q3 2025, -$188000.0 in Q2 2025, and $52000.0 in Q1 2025.